SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cookie Monster who wrote (153)12/9/1998 10:35:00 PM
From: JimBeamII  Read Replies (1) of 1084
 
Cookie Monster -- the product will be marketed in Europe by "the end of the year" -- this year. It's been tested on humans, successfully. This is a BIG DISTINCTION from GERN, ENMD, etc.

Other big distinctions is the float. Bio-tech histories are rather difficult to depend on in most cases because virtually all biotechs are money losers for many years due to the time it takes to get their product out the door. Here, ASTM has a product and is preparing to market it in the near term.

If it opens under $10 I'd be surprised. IMO, the correct strategy is to put your stop order to sell $1.50 under the bid about 2 minutes before the open. When it takes off, as I believe it will, keep increasing your stop. If by 9:50 its still running, relax and wait for high teens and 20s. I don't look for it to fall as fast as some of the nets or GERN, simply because of the existing product and the demand it will have by hospitals and other health providers. See Bo Didley's paste in one of his previous posts.

Prosperous Trading!
jb
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext